mAbxience | farmacovigilancia
Manuel Pombo Angulo 28 3rd floor, Madrid Postal code: 28050 Spain Email: pharmacovigilance@mabxience.com
SuspectedConcomitant MedicationUsed for treatment of the side effect
Start Date: End Date:
Select formulationCreamCapsuleDropSolutionPatchTabletunknownOther
Please selectCutaneous- on the skinInhalationIntramuscularIntrathecalIntravenousNasalOphthalmicOralParentheralRectalSubcutaneousSublingualTransdermalTransplacentalUnknownVaginalOther
Select dose unitmg (milligram)ug (microgram)mg/kg (milligram/kilogram)Gtt (Drop)DF (Dosage Form)kg (kilogram)g (gram)ml (mililitre)% (percent)ug/kg (microgram/kilogram)ul (microlitre)mbq (mecabequeral)mol (mole)mmol (milimole)umol (micromole)IU (international Unit)
Please selectOnce dailyTwice a dayThree Times a dayFour times a dayEvery eveningEvery 12 hoursEvery 48 hoursEvery 72 hoursEvery other dayOnce a weekOnce every two weeksOnce a monthOne single doseAs neededOther
Select the outcomeComplete recoveryClinical deteriorationClinical improvementNo modification observedFatalRecovered with sequelaeUnknown
UnknownNo, it was not seriousYes, it was serious
Resulted in deathWas life threateningResulted in or prolonged hospitalizationResulted in a disability or was incapacitatingResulted in a congenital anomaly or birth defectMedically Significant
MaleFemaleUnknown
AgesMonthsDays
CmFeetInches
KilogramsPounds
Select reporter typeHealth Care ProfessionalPatient/ConsumerOther Non-Health Care ProfessionalHealth Authority
Yes, contact my health care professional for more information about this reportNo, you cannot contact my health care professional
Yes, you can contact meNo, you cannot contact me